Koseido (02273) accelerates overseas expansion and plans to fully acquire Singapore's Dazhong Tang to add 14 Chinese medicine clinics to its operations.

Zhixin Finance APP learned that on November 16, 2025, Gushengtang Singapore, a subsidiary of Gu Sheng Tang, signed a share transfer agreement with the shareholders of DA ZHONG TANG PTE. LTD., intending to acquire 100% equity of DA ZHONG TANG. Following a strategic partnership reached with the Singapore digital healthcare platform 1doc in October this year, this acquisition marks another important strategic deployment for Gu Sheng Tang (02273) in overseas markets, signifying the acceleration of their traditional Chinese medicine overseas strategy.